Skip to main content
. 2015 Mar 20;128(6):721–726. doi: 10.4103/0366-6999.152460

Figure 1.

Figure 1

Cumulative 5-year incidences of major adverse cardiovascular events (a); cardiovascular death (b); target lesion revascularization (c); and myocardial infarction (d) in patients who underwent drug-eluting stent implantation and bare-metal stent implantation.